The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.
Saved in:
| Title: | The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group. |
|---|---|
| Authors: | Kim BJ; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea., Maeng CH; Department of Medical Oncology and Hematology, Kyung Hee University Hospital, Seoul, Korea., Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Im YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Ro J; Division of Internal Medicine, Center for Breast Cancer, National Cancer Center, Goyang, Korea., Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Im SA; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Heo DS; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Kim HK; Division of Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea., Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Cho JY; Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Yun HJ; Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea., Nam BH; HERINGS, The Institute of Advanced Clinical & Biomedical Research, Seoul, Korea., Zang DY; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea. |
| Source: | Cancer research and treatment [Cancer Res Treat] 2025 Jan; Vol. 57 (1), pp. 39-46. Date of Electronic Publication: 2024 Jul 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2005-9256 |
|---|---|
| DOI: | 10.4143/crt.2024.421 |
